About MirImmune

About company

MirImmune is a biopharmaceutical company focused on the development of new and improved immunotherapies for cancer. Aiming to achieve long-term survival of cancer patients, MirImmune combine two leading approaches to cancer treatment: immune checkpoint inhibition and cell-based immunotherapies.